文献速递外周动脉疾病

小直径Viabahn覆膜支架在外周动脉疾病中的中期通畅率是否与支架长度相关?一项系统综述

Is the Mid-Term Patency Rate of Small-Diameter Viabahn Stent-Grafts in Peripheral Artery Disease Related to Their Length? A Systematic Review.
PubMed 文献 · J Endovasc Ther · 2023-06-08

本系统综述纳入截至2020年9月发表的23项研究(16项回顾性、7项前瞻性),共1613例患者,评估≤7 mm直径Viabahn覆膜支架治疗外周动脉疾病的中期通畅率及其与支架长度的关系。1年和5年一期通畅率分别为75.7%(95% CI,73.6%-77.8%)和46.8%(95% CI,41.0%-52.6%),未发现支架长度与通畅率之间存在相关性。作者认为小直径Viabahn覆膜支架植入是安全治疗,中期通畅率似乎不受支架长度影响。

要点

  • 1年一期通畅率75.7%(95% CI,73.6%-77.8%),5年一期通畅率46.8%(95% CI,41.0%-52.6%)。
  • 1年一期辅助通畅率80.9%(95% CI,73.9%-87.8%),5年一期辅助通畅率60.9%(95% CI,46.4-75.5%)。
  • 1年二期通畅率90.4%(95% CI,87.4%-93.3%),5年二期通畅率73.7%(95% CI,64.7%-82.8%)。

核心结论

  • 小直径Viabahn覆膜支架植入对于外周动脉疾病患者是一种安全的治疗,中期通畅率似乎不受支架长度影响。

研究设计与样本

  • 系统综述纳入截至2020年9月发表的报道使用≤7 mm直径Viabahn覆膜支架治疗病变外周动脉的文章,共16项回顾性研究和7项前瞻性研究,1613例患者(平均年龄69.6±33.7岁)。

主要发现

  • Viabahn覆膜支架直径为5至7 mm,平均长度23.6±12.4 cm,46.4%的病例使用肝素涂层支架,平均随访时间26.4±17.6个月。
  • 1年和5年一期通畅率分别为75.7%(95% CI,73.6%-77.8%)和46.8%(95% CI,41.0%-52.6%)。
  • 1年和5年一期辅助通畅率分别为80.9%(95% CI,73.9%-87.8%)和60.9%(95% CI,46.4-75.5%)。
  • 1年和5年二期通畅率分别为90.4%(95% CI,87.4%-93.3%)和73.7%(95% CI,64.7%-82.8%)。
  • 未发现支架长度与通畅率之间存在相关性。

关键数值与推荐

  • 各研究间报告标准存在 considerable 异质性(原文用 considerable heterogeneity,未报告具体数值)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 各研究间报告标准存在 considerable 异质性(原文未报告具体数值)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Small-diameter endografts can be used for the treatment of the peripheral vascular disease, but the patency rate during the follow-up is still under debate. With this review, we aimed at analyzing the mid-term patency of small-diameter Viabahn stent-grafts and investigating the relationship between patency and the length of the graft. METHODS: We performed a review of articles published until September 2020 and reporting use of ≤7-mm-diameter Viabahn stent-grafts in diseased peripheral arteries. Data on study type, demographic, lesion length, stent-graft diameter, length, and patency (1-year, 3-year, 5-year primary patency, primary-assisted patency, and secondary patency), follow-up, endoleak, and re-intervention rates were extracted and analyzed. A statistical test was applied to identify a correlation between stent-graft length and patency. RESULTS: 16 retrospective and 7 prospective studies reported the outcome of 1613 patients (mean age: 69.6±33.7 years). There was considerable heterogeneity in reporting standards among studies. The diameter of Viabahn stent-grafts ranged 5 to 7mm and the average length was 23.6±12.4cm. Heparin-bonded grafts were used in 46.4% of cases. Mean follow-up time was 26.4±17.6 months. The 1- and 5-year primary patency rate was 75.7% (95% CI, 73.6%-77.8%) and 46.8% (95% CI, 41.0%-52.6%), respectively. The 1- and 5-year primary-assisted patency rate was 80.9% (95% CI, 73.9%-87.8%) and 60.9% (95% CI, 46.4-75.5%), respectively. The 1- and 5-year second-assisted patency was 90.4% (95% CI, 87.4%-93.3%) and 73.7% (95% CI, 64.7%-82.8%), respectively. No correlation between the stent-graft length and patency was found. CONCLUSIONS: Small-diameter Viabahn stent-graft implantation represents a safe treatment for patients with peripheral artery disease, and the mid-term patency rate seems not be affected by the length of the graft.Clinical ImpactThe use of small diameter stent-grafts for peripheral vascular disease is an established technique but the patency rate is still under debate. With this review we have investigated the relationship between the mid-term patency and the diameter of the stent-grafts. Afterv having analysed data from 23 published studies including 1613 patients we can conclude that the treatment of the peripheral artery disease with small diameter stent-grafts is safe and the mid-term patency rate seems not be affected by the lenght of the grafts.

来源:J Endovasc Ther,查看原文。版权归原作者所有。

引用

  1. Ferrari E, Wang C, Tozzi P, et al. Is the Mid-Term Patency Rate of Small-Diameter Viabahn Stent-Grafts in Peripheral Artery Disease Related to Their Length? A Systematic Review. J Endovasc Ther. 2023. PMID: 37291964. doi:10.1177/15266028231179782

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。